Results 21 to 30 of about 1,301,573 (319)

The Effects of Inhaled Steroid and Theophylline on Systemic Inflammation in Copd

open access: yesEuropean Journal of Inflammation, 2011
Chronic obstructive pulmonary disease (COPD) is a systemic disease characterized by chronic, progressive airflow limitation and airway inflammation. In this study, our aim is to compare the effects of inhaled corticosteroids and theophylline on systemic ...
H. Boyaci   +5 more
doaj   +1 more source

Circulating choline levels are associated with prognoses in patients with pulmonary hypertension: a cohort study

open access: yesBMC Pulmonary Medicine, 2023
Backgrounds Mounting evidences have highlighted the association between metabolites and cardiovascular diseases. Our previous works have demonstrated that circulating metabolite, trimethylamine oxide, was associated with prognosis of patients with ...
Yicheng Yang   +8 more
doaj   +1 more source

COgnitive-Pulmonary Disease [PDF]

open access: yesBioMed Research International, 2014
Over the past few decades, chronic obstructive lung disease (COPD) has been considered a disease of the lungs, often caused by smoking. Nowadays, COPD is regarded as a systemic disease. Both physical effects and effects on brains, including impaired psychological and cognitive functioning, have been demonstrated.
Cleutjens, F.A.H.M.   +4 more
openaire   +3 more sources

Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report

open access: yesESC Heart Failure, 2023
Intravenous (i.v.) prostacyclin is the cornerstone treatment in high‐risk pulmonary arterial hypertension (PAH) patients. Selexipag is an orally available prostacyclin receptor agonist.
André Alexandre   +7 more
doaj   +1 more source

Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review [PDF]

open access: yes, 2009
Exacerbations of chronic obstructive pulmonary disease (COPD) are important events in the natural history of this prevalent and devastating condition. This review provides a concise, state of the art summary on prevention and management of exacerbations.
Hurst, JR   +5 more
core   +1 more source

Relationship between ID1 and EGFR-TKI Resistance 
in Non-small Cell Lung Cancer

open access: yesChinese Journal of Lung Cancer, 2016
Background and objective Non-small cell lung cancer (NSCLC) presents the highest morbidity and mortality among malignant tumors worldwide. The overall effective rate of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is 30% to 40 ...
Yuchen BAO   +7 more
doaj   +1 more source

Progress in the Metabolomics of Acute Coronary Syndrome

open access: yesReviews in Cardiovascular Medicine, 2023
Acute coronary syndrome (ACS) is a severe type of coronary heart disease (CHD) with increasing prevalence and significant challenges for prevention and treatment.
Fu Zhang   +7 more
doaj   +1 more source

Autophagy in Pulmonary Diseases [PDF]

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2016
Abstract The pathogenesis of pulmonary diseases is often complex and characterized by multiple cellular events, including inflammation, cell death, and cell proliferation. The mechanisms by which these events are regulated in pulmonary diseases remain poorly understood.
Kiichi, Nakahira   +2 more
openaire   +2 more sources

Cavitary Legionella Pneumonia in AIDS: When Intracellular Immunity Failure Leads to Rapid Intrapulmonary Cavitation

open access: yesCase Reports in Pulmonology, 2021
Introduction. Legionella is a frequent cause of bacterial pneumonia in patients with AIDS. While multiple organisms have been associated with cavitary pneumonia in this population, Legionella has not. Clinical Case.
Richard Jesse Durrance   +3 more
doaj   +1 more source

The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients

open access: yesBMC Pulmonary Medicine, 2019
Background Pulmonary Hypertension Association UK (PHA-UK) is the only charity in the UK especially for people affected by pulmonary hypertension (PH).
Iain Armstrong   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy